In vitro modulation of cytokine expression by enkephalin-derived peptides

NeuroImmunoModulation

Volumn 12, Issue 6, 2006, Pages 339-347

  Piva, Marta ^a   Moreno, J Ignacio ^a   Jenkins, Fameeka S ^a   Smith, Jimmie K A ^a   Thomas, Jenetria L ^a   Montgomery, Corey ^a   Wilson, Caleph B ^a   Sizemore, Robert C ^a  

^a ALCORN STATE UNIVERSITY   (United States)

Author keywords

Met5 enkephalin; Interferon ; Interleukin 2; Interleukin 4; YG; YGG

Indexed keywords

CONCANAVALIN A; CYTOKINE; ENKEPHALIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; METENKEPHALIN; PEPTIDE DERIVATIVE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ASSAY; CELL STIMULATION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; SUPERNATANT; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; ENKEPHALIN, METHIONINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; LYMPHOCYTE ACTIVATION; MICE; PEPTIDES; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 33645579488     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091127     Document Type: Article

References (41)

1. Adler R, Felter DL, Cohen N (eds): Psychoneuroimmunology, ed 3. San Diego, Academic Press, 2001.
2. Jankovic BD, Maric D: Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Ann NY Acad Sci 1987;496:115-125.
3. Maric D, Jankovic BD: Enkephalins and immunity. II. In vivo modulation of cell-mediated immunity. Ann NY Acad Sci 1987;496:126-136.
4. 5]-enkephalin fragments. Eur J Pharmacol 1998;347:95-99.
5. Kowalski J, Makowiecka K, Belowski D, Herman ZS: Augmenting effect of methionine-enkephalin on interleukin-6 production by cytokine-stimulated murine macrophages. Neuropeptides 2000;34:187-192.
6. Heagy W, Laurance M, Cohen E, Finberg R: Neurohormones regulate T cell function. J Exp Med 1990;171:1625-1633.
7. Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J: Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues. Immunopharmacology 1990;19:87-91.
8. Haberstock H, Marotti T: The relevance of intact enkephalin molecule in predominantly delta opioid receptor mediated superoxide anion release. Neuropeptides 1995;29:357-365.
9. 5]-enkephalin differentially affect IgM and IgG production by B cells. J Neuroimmunol 1997;73:37-46.
10. Schwartz JC, Malfroy B, De La Baume S: Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase ('enkephalinase') as neuropeptidase. Life Sci 1981;29:1715-1740.
11. Amoscato AA, Spiess RR, Sansoni SB, Herberman RB, Chambers WH: Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases. Brain Behav Immun 1993;7:176-187.
12. Marini M, Urbani A, Bongiorno L, Roda LG: Soluble enkephalin-degrading enzymes released by lymphomic and erythroleukaemic cell lines. Neurochem Res 1992;17:1155-1161.
13. Sizemore RC, Dienglewicz RL, Pecunia E, Gottlieb AA: Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by leu-enkephalin and related peptides. Clin Immunol Immunopathol 1991;60:310-318.
14. Kayser H, Meisel H: Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett 1996;383:18-20.
15. Sizemore RC, Piva M, Moore L, Gordonov N, Heilman E, Godfrey HP: Modulation of delayed-type hypersensitivity responses in hairless guinea pigs by peptides derived from enkephalin. Neuroimmunomodulation 2004;11:141-148.
16. Sinha SK, Sizemore RC, Gottlieb AA: Immunomodulatory components present in IMREG-1, an experimental immunosupportive biologic. Biotechnology 1988;6:810-815.
17. Brown SL, Van Epps DE: Opioid peptides modulate production of interferon gamma by human mononuclear cells. Cell Immunol 1986;103:19-26.
18. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ: Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 2001;62:111-123.
19. Carr DJ, Kim CH, deCosta B, Jacobson AE, Rice KC, Blalock JE: Evidence for a delta-class opioid receptor on cells of the immune system. Cell Immunol 1988;116:44-51.
20. Carr DJ, DeCosta BR, Kim CH, Jacobson AE, Guarcello V, Rice KC, Blalock JE: Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J Endocrinol 1989;122:161-168.
21. Carr DJ, Blalock JE, Bost KL: Monoclonal antibody against a peptide specified by [Met]-enkephalin complementary RNA recognizes the delta-class opioid receptor. Immunol Lett 1989;20:181-186.
22. Miller B: Delta opioid receptor expression is induced by concanavalin A in CD4+ T cells. J Immunol 1996;157:5324-5328.
23. Mansour A, Hoversten MT, Taylor LP, Watson SJ, Akil H: The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. Brain Res 1995;700:89-98.
24. Buscher HH, Hill RC, Romer D, Cardinaux F, Closse A, Hauser D, Pless J: Evidence for analgesic activity of enkephalin in the mouse. Nature 1976;261:423-425.
25. Calabrese EJ, Baldwin LA: Applications of hormesis in toxicology, risk assessment and chemotherapeutics. Trends Pharmacol Sci 2002;23:331-337.
26. Moreno JI, Piva M, Sizemore RC: Peptidase-mediated regulation of met-enkephalin activity by ConA-activated murine splenocytes, in preparation.
27. Foris G, Medgyesi GA, Hauck M: Bidirectional effect of met-enkephalin on macrophage effector functions. Mol Cell Biochem 1986;69:127-137.
28. Foris G, Medgyesi GA, Nagy JT, Varga Z: Concentration-dependent effect of met-enkephalin on human polymorphonuclear leukocytes. Ann NY Acad Sci 1987;496:151-157.
29. Powrie F, Coffman RL: Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993;14:270-274.
30. Clerici M, Shearer GM: A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
31. Salk J, Bretscher PA, Salk PL, Clerici M, Shearer GM: A strategy for prophylactic vaccination against HIV. Science 1993;260:1270-1272.
32. Firestein GS, Roeder WD, Laxer JA, Townsend KS, Weaver CT, Hom JT, Linton J, Torbett BE, Glasebrook AL: A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immunol 1989;143:518-525.
33. Trinchieri G: Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 1993;14:335-338.
34. Perussia B, Loza MJ: Linear '2-0-1' lymphocyte development: hypotheses on cellular bases for immunity. Trends Immunol 2003;24:235-241.
35. Loza MJ, Perussia B: Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol 2002;169:3061-3068.
36. Cottrez F, Hurst SD, Coffman RL, Groux H: T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165:4848-4853.
37. Weiner HL: Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001;182:207-214.
38. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA: Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25-precursors. J Immunol 2002;169:4183-4189.
39. Dhabhar FS, McEwen BS: Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun 1997;11:286-306.
40. Fischer EG: Opioid peptides modulate immune functions. A review. Immunopharmacol Immunotoxicol 1988;10:265-326.
41. Tasiemski A, Verger-Bocquet M, Cadet M, Goumon Y, Metz-Boutigue MH, Aunis D, Stefano GB, Salzet M: Proenkephalin A-derived peptides in invertebrate innate immune processes. Brain Res Mol Brain Res 2000;76:237-252.